Evaluation of Surgical Excision of Cardiophrenic Lymph Nodes in Patients With Advanced Ovarian Cancer

Evaluation of Surgical Excision of Cardiophrenic Lymph Nodes in Patients With Advanced Ovarian Cancer

Evaluation of surgical excision of cardiophrenic lymph nodes in patients with advanced ovarian cancer

The role of cardiophrenic lymph node assessment and excision in advanced ovarian cancer is still debatable , correlation of radiological finding with pathological findings after reaction of radiological positive lymph nodes and its impact in diseases free survival and over all survival

Inclusion criteria

• Ovarian cancer patient (FIGO stage III-IV)
• Preoperative CT showing CPLN with short axis diameter > 5mm.
• Anathestically fit patient (ASA score I or II).
• Accepted pulmonary function test.
• Patient who received neoadjuvant chemotherapy or recurrent cases may be enrolled
• Written informed consent.
• Achievement of optimal cytoreduction intra-abdominal( No residual disease more than 1 cm )

Exclusion Criteria:

• Anathestically unfit patient
• Unresectable disease
• Patient refusal
• No detected CPLN by preoperative radiology